Switch to:
More From Other Websites
Orexigen Therapeutics Gains On Diet Pill Nod From European Committee Dec 19 2014
Orexigen's 'Goldilocks' Weight-Loss Pill is Just Right for European Regulators Dec 19 2014
Bio-Twitter Sentiment Favors European Orexigen Obesity Pill Approval Dec 17 2014
VIVUS Announces Favorable Formulary Positioning for Qsymia Dec 15 2014
VIVUS Announces Favorable Formulary Positioning for Qsymia Dec 15 2014
Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals Dec 12 2014
Others Overlooked VIVUS (VVUS), Should You Buy It Now? Dec 09 2014
Europe shares open higher; oil price watched Dec 02 2014
Cramer: State of holiday retail Dec 01 2014
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 26 2014
VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia Nov 26 2014
VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia Nov 26 2014
Why VIVUS (VVUS) Might Be a Diamond in the Rough Nov 19 2014
VIVUS INC Financials Nov 14 2014
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 12 2014
Orexigen rises as weight loss drug review proceeds Nov 10 2014
Orexigen rises as weight loss drug review proceeds Nov 10 2014
10-Q for VIVUS, Inc. Nov 07 2014
VIVUS Posts Narrower-than-Expected Q3 Loss, Revenues Up Nov 06 2014
Vivus tops Street 3Q forecasts Nov 05 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK